Skip to main content

Advertisement

SpringerLink
Log in

Tofacitinib-induced progressive multifocal leukoencephalopathy–immune reconstitution inflammatory syndrome

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Tan CS, Koralnik IJ (2010) Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 9(4):425–437. https://doi.org/10.1016/S1474-4422(10)70040-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Wathes R, Moule S, Milojkovic D (2013) Progressive multifocal leukoencephalopathy associated with ruxolitinib. N Engl J Med 369(2):197–198. https://doi.org/10.1056/NEJMc1302135

    Article  CAS  PubMed  Google Scholar 

  3. Kucharz EJ, Stajszczyk M, Kotulska-Kucharz A, Batko B, Brzosko M, Jeka S, Leszczyński P, Majdan M, Olesińska M, Samborski W, Wiland P (2018) Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology. Reumatologia 56(4):203–211. https://doi.org/10.5114/reum.2018.77971

    Article  PubMed  PubMed Central  Google Scholar 

  4. Yun J, Osehobo E, Lawson EC, Harrison T, Harrison A (2022) Tofacitinib-induced progressive multifocal leukoencephalopathy with immune reconstitution inflammatory syndrome. Clin Neurol Neurosurg 214:107143. https://doi.org/10.1016/j.clineuro.2022.107143

    Article  PubMed  Google Scholar 

  5. Fournier A, Martin-Blondel G, Lechapt-Zalcman E, Dina J, Kazemi A, Verdon R, Mortier E, de La Blanchardière A (2017) Immune reconstitution inflammatory syndrome unmasking or worsening AIDS-related progressive multifocal leukoencephalopathy: a literature review. Front Immunol 23(8):577. https://doi.org/10.3389/fimmu.2017.00577

    Article  CAS  Google Scholar 

  6. Frémond ML, Crow YJ (2021) STING-mediated lung inflammation and beyond. J Clin Immunol 41(3):501–514. https://doi.org/10.1007/s10875-021-00974-z

    Article  PubMed  Google Scholar 

  7. Frémond ML, Hadchouel A, Berteloot L, Melki I, Bresson V, Barnabei L, Jeremiah N, Belot A, Bondet V, Brocq O, Chan D, Dagher R, Dubus JC, Duffy D, Feuillet-Soummer S, Fusaro M, Gattorno M, Insalaco A, Jeziorski E, Kitabayashi N, Lopez-Corbeto M, Mazingue F, Morren MA, Rice GI, Rivière JG, Seabra L, Sirvente J, Soler-Palacin P, Stremler-Le Bel N, Thouvenin G, Thumerelle C, Van Aerde E, Volpi S, Willcocks S, Wouters C, Breton S, Molina T, Bader-Meunier B, Moshous D, Fischer A, Blanche S, Rieux-Laucat F, Crow YJ, Neven B (2021) Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients. J Allergy Clin Immunol Pract 9(2):803-818.e11. https://doi.org/10.1016/j.jaip.2020.11.007

    Article  CAS  PubMed  Google Scholar 

  8. Volpi S, Insalaco A, Caorsi R, Santori E, Messia V, Sacco O, Terheggen-Lagro S, Cardinale F, Scarselli A, Pastorino C, Moneta G, Cangemi G, Passarelli C, Ricci M, Girosi D, Derchi M, Bocca P, Diociaiuti A, El Hachem M, Cancrini C, Tomà P, Granata C, Ravelli A, Candotti F, Picco P, DeBenedetti F, Gattorno M (2019) Efficacy and adverse events during janus kinase inhibitor treatment of SAVI syndrome. J Clin Immunol 39(5):476–485. https://doi.org/10.1007/s10875-019-00645-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Li W, Wang W, Wang W, Zhong L, Gou L, Wang C, Ma J, Quan M, Jian S, Tang X, Zhang Y, Wang L, Ma M, Song H (2022) Janus kinase inhibitors in the treatment of type I interferonopathies: a case series from a single center in China. Front Immunol 13:825367. https://doi.org/10.3389/fimmu.2022.825367

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Hadassah Medical Center, Jerusalem, Israel

    Yoel Schwartzmann, Adi Vaknin-Dembinsky, Netta Levin, Dana Ekstein, Jad Magadle & Marc Gotkine

  2. Faculty of Medicine, Hebrew University, Jerusalem, Israel

    Adi Vaknin-Dembinsky, John Moshe Gomori, Hila Elinav, Yackov Berkun, Netta Levin, Dana Ekstein & Marc Gotkine

  3. Department of Neuroradiology, Hadassah Medical Center, Jerusalem, Israel

    John Moshe Gomori

  4. Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center, Jerusalem, Israel

    Hila Elinav

  5. Department of Pediatrics, Hadassah Medical Center, Jerusalem, Israel

    Yackov Berkun

Authors
  1. Yoel Schwartzmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adi Vaknin-Dembinsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John Moshe Gomori
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hila Elinav
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yackov Berkun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Netta Levin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dana Ekstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jad Magadle
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Marc Gotkine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoel Schwartzmann.

Ethics declarations

Ethical approval

None.

Conflict of interest

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schwartzmann, Y., Vaknin-Dembinsky, A., Gomori, J.M. et al. Tofacitinib-induced progressive multifocal leukoencephalopathy–immune reconstitution inflammatory syndrome. Neurol Sci 44, 3737–3739 (2023). https://doi.org/10.1007/s10072-023-06897-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-023-06897-4

Search

Navigation